Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Revenue (2025)

Historic Revenue for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to $237441.0.

  • Coeptis Therapeutics Holdings' Revenue changed N/A to $237441.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $500996.0, marking a year-over-year change of. This contributed to the annual value of $75000.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Revenue of $237441.0 as of Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Revenue peaked at $237441.0 during Q3 2025, and registered a low of $62874.0 during Q1 2025.